Welcome to ScanCLAD | ScanCLAD, ScanCLAD is an investigator initiated, controlled, randomized, open-label, and multi-centre study evaluating if once-daily tacrolimus or twice-daily cyclosporin, reduces the 3-year incidence of Chronic Lung Allograft Dysfunction after lung transplantation (EudraCT number 2015-004137-27) The study started in the end of 2016, and is planned to continue through 2022 for follow.